查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386463

左心耳封堵器市場報告：2030 年趨勢、預測與競爭分析

Left Atrial Appendage Closure Devices Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

左心耳封堵器的趨勢與預測

預計到 2030 年，全球左心耳封堵器市場將達到 38 億美元，2024 年至 2030 年年複合成長率為 17.7%。這個市場的主要促進因素是心房顫動 (AF) 病例的增加、最尖端科技的日益採用以及全球生活方式的紊亂。全球左心耳封堵器市場的未來充滿希望，醫院和門診手術中心市場充滿機會。

左心耳封堵器市場洞察

Lucintel 預測，在預測期內，心內膜將繼續佔據更大的佔有率，因為它將用於併發症更少、住院時間更短、30 天再入院次數更少的患者。

由於對左心房顫動 (LAA) 手術的偏好不斷增加以及醫院對左心房顫動封堵裝置的接受度不斷提高，醫院將繼續成為該市場的最大細分市場。

由於心房顫動的增加和高齡化，北美仍然是最大的市場。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球左心耳封堵器市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球左心耳封堵器市場趨勢（2018-2023）與預測（2024-2030）
  • 全球左心耳封堵器市場（按產品）
    • 心外膜
    • 心內膜
  • 全球左心耳封堵器市場（依最終用途）
    • 醫院
    • 門診手術中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球左心耳封堵器市場區域分佈
  • 北美左心耳封堵器市場
  • 歐洲左心耳封堵器市場
  • 亞太地區左心耳封堵器市場
  • 其他地區左心耳封堵器市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球左心耳封堵器市場成長機會（按產品）
    • 全球左心耳封堵器市場成長機會（依最終用途）
    • 全球左心耳封堵器市場成長機會（按地區）
  • 全球左心耳封堵器市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球左心耳封堵器市場產能擴張
    • 全球左心耳封堵器械市場的合併、收購及合資企業
    • 認證和許可

第7章 主要企業概況

  • Abbott Laboratories
  • AtriCure
  • Johnson & Johnson
  • Aegis Medical
  • Cardia
  • Biosense Webster
  • Sentreheart
  • Occlutech
  • Boston Scientific Corporation
  • Lifetech Scientific Corporation
簡介目錄

Left Atrial Appendage Closure Devices Trends and Forecast

The future of the global left atrial appendage closure devices market looks promising with opportunities in the hospitals and ambulatory surgery centers markets. The global left atrial appendage closure devices market is expected to reach an estimated $3.8 billion by 2030 with a CAGR of 17.7% from 2024 to 2030. The major drivers for this market are growing cases of atrial fibrillation (AF), increasing adoption of cutting-edge technologies, and disrupted lifestyle behaviors across the globe.

A more than 150-page report is developed to help in your business decisions.

Left Atrial Appendage Closure Devices by Segment

The study includes a forecast for the global left atrial appendage closure devices by product, end use, and region.

Left Atrial Appendage Closure Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Epicardial
  • Endocardial

Left Atrial Appendage Closure Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Left Atrial Appendage Closure Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Left Atrial Appendage Closure Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies left atrial appendage closure devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the left atrial appendage closure devices companies profiled in this report include-

  • Abbott Laboratories
  • Atricure
  • Johnson & Johnson
  • Aegis Medical
  • Cardia
  • Biosense Webster
  • Sentreheart
  • Occlutech
  • Boston Scientific Corporation
  • Lifetech Scientific Corporation

Left Atrial Appendage Closure Devices Market Insights

Lucintel forecasts that endocardial will remain the larger segment over the forecast period as it is used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions.

Within this market, hospitals will remain the largest segment due to growing preference for left atrial appendage (LAA) procedures and an increase in hospital acceptance of left atrial appendage closure devices.

North America iwill remain the largest region due to rising incidences of atrial fibrillation and increasing aging population in the region.

Features of the Global Left Atrial Appendage Closure Devices Market

Market Size Estimates: Left atrial appendage closure devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Left atrial appendage closure devices market size by product, end use, and region in terms of value ($B).

Regional Analysis: Left atrial appendage closure devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, end uses, and regions for the left atrial appendage closure devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the left atrial appendage closure devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the left atrial appendage closure devices market size?

Answer: The global left atrial appendage closure devices market is expected to reach an estimated $3.8 billion by 2030.

Q.2 What is the growth forecast for left atrial appendage closure devices market?

Answer: The global left atrial appendage closure devices market is expected to grow with a CAGR of 17.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the left atrial appendage closure devices market?

Answer: The major drivers for this market are growing cases of atrial fibrillation (AF), increasing adoption of cutting-edge technologies, and disrupted lifestyle behaviors across the globe.

Q4. What are the major segments for left atrial appendage closure devices market?

Answer: The future of the left atrial appendage closure devices market looks promising with opportunities in the hospital and ambulatory surgery center markets.

Q5. Who are the key left atrial appendage closure devices market companies?

Answer: Some of the key left atrial appendage closure devices companies are as follows:

  • Abbott Laboratories
  • AtriCure
  • Johnson & Johnson
  • Aegis Medical
  • Cardia
  • Biosense Webster
  • Sentreheart
  • Occlutech
  • Boston Scientific Corporation
  • Lifetech Scientific Corporation

Q6. Which left atrial appendage closure devices market segment will be the largest in future?

Answer: Lucintel forecasts that endocardial will remain the larger segment over the forecast period as it is used in patients featured lower complications, shorter hospital stays, and fewer 30-day readmissions.

Q7. In left atrial appendage closure devices market, which region is expected to be the largest in next 5 years?

Answer: North America iwill remain the largest region due to rising incidences of atrial fibrillation and increasing aging population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the left atrial appendage closure devices market by type (epicardial and endocardial), end use (hospitals, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Left Atrial Appendage Closure Devices Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Left Atrial Appendage Closure Devices Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Left Atrial Appendage Closure Devices Market by Product
    • 3.3.1: Epicardial
    • 3.3.2: Endocardial
  • 3.4: Global Left Atrial Appendage Closure Devices Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Ambulatory Surgery Centers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Left Atrial Appendage Closure Devices Market by Region
  • 4.2: North American Left Atrial Appendage Closure Devices Market
    • 4.2.1: North American Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
    • 4.2.2: North American Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.3: European Left Atrial Appendage Closure Devices Market
    • 4.3.1: European Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
    • 4.3.2: European Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.4: APAC Left Atrial Appendage Closure Devices Market
    • 4.4.1: APAC Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
    • 4.4.2: APAC Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.5: ROW Left Atrial Appendage Closure Devices Market
    • 4.5.1: ROW Left Atrial Appendage Closure Devices Market by Product: Epicardial and Endocardial
    • 4.5.2: ROW Left Atrial Appendage Closure Devices Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by Product
    • 6.1.2: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by End Use
    • 6.1.3: Growth Opportunities for the Global Left Atrial Appendage Closure Devices Market by Region
  • 6.2: Emerging Trends in the Global Left Atrial Appendage Closure Devices Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Left Atrial Appendage Closure Devices Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Left Atrial Appendage Closure Devices Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: AtriCure
  • 7.3: Johnson & Johnson
  • 7.4: Aegis Medical
  • 7.5: Cardia
  • 7.6: Biosense Webster
  • 7.7: Sentreheart
  • 7.8: Occlutech
  • 7.9: Boston Scientific Corporation
  • 7.10: Lifetech Scientific Corporation